Brief: Clinuvel Pharmaceuticals Says Scenesse Applied Under 5 Year U.S. Veterans Affairs Contract
26/07/2023 02:28
July 26 (Reuters) - Clinuvel Pharmaceuticals Ltd
CUV.AX :
* SCENESSE APPLIED UNDER 5 YEAR US VETERANS AFFAIRS CONTRACT
* AWARDED A FIVE-YEAR CONTRACT BY U.S. DEPARTMENT OF
VETERANS
AFFAIRS
* CONTRACT TO SUPPLY SCENESSE® (AFAMELANOTIDE) FOR ADULT
ERYTHROPOIETIC PROTOPORPHYRIA (EPP) PATIENTS.
Source text for Eikon: ID:nASX1RlVRw
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist